These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
815 related articles for article (PubMed ID: 29554790)
1. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery. Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790 [TBL] [Abstract][Full Text] [Related]
2. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study. Lin X; Yao J; Huang B; Chen T; Xie L; Huang R Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873 [TBL] [Abstract][Full Text] [Related]
3. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database. Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464 [TBL] [Abstract][Full Text] [Related]
4. Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer. Jiang L; Jiang S; Lin Y; Yang H; Xie Z; Lin Y; Long H Medicine (Baltimore); 2015 Nov; 94(46):e2054. PubMed ID: 26579815 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung. Li H; Wang Z; Yang F; Wang J J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478 [TBL] [Abstract][Full Text] [Related]
6. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation. Chai Y; Ma Y; Feng W; Lu H; Jin L World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection. Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study. Zhang Y; Zheng D; Xie J; Li Y; Wang Y; Li C; Xiang J; Zhang Y; Hu H; Sun Y; Chen H Chest; 2018 Sep; 154(3):501-511. PubMed ID: 29758181 [TBL] [Abstract][Full Text] [Related]
9. A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients. Sun F; Ma K; Yang X; Li M; Shi Y; Zhan C; Jiang W; Wang Q Int J Surg; 2017 Jun; 42():11-16. PubMed ID: 28428062 [TBL] [Abstract][Full Text] [Related]
10. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database. Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223 [TBL] [Abstract][Full Text] [Related]
11. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number. Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511 [TBL] [Abstract][Full Text] [Related]
12. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma? Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438 [TBL] [Abstract][Full Text] [Related]
14. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer. Huang X; Hu P; Yan F; Zhang J Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800 [No Abstract] [Full Text] [Related]
15. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy. Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463 [TBL] [Abstract][Full Text] [Related]
16. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis. Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966 [TBL] [Abstract][Full Text] [Related]
17. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer. Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135 [TBL] [Abstract][Full Text] [Related]
18. The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model. Ma S; Li Z; Wang L World J Surg Oncol; 2024 Jun; 22(1):158. PubMed ID: 38877553 [TBL] [Abstract][Full Text] [Related]
19. Nomogram to predict overall survival after gallbladder cancer resection in China. Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393 [TBL] [Abstract][Full Text] [Related]
20. Survival benefits associated with surgery for advanced non-small cell lung cancer. David EA; Andersen SW; Beckett LA; Melnikow J; Clark JM; Brown LM; Cooke DT; Kelly K; Canter RJ J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1620-1628. PubMed ID: 30551965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]